US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 3.770
  • -0.230-5.75%
Close Sep 27 16:00 ET
  • 3.800
  • +0.030+0.80%
Post 20:02 ET
235.25MMarket Cap-11088P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics Q2 2024 Earnings Date

Currency：USDJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
41.11M
80.00M
+38.89M
Beat Est.
+4571.96%
+8990.91%
+94.58%
EPS
-0.01
0.87
+0.88
Beat Est.
+96.74%
+328.95%
+7116.13%
Analyst Rating
Buy

Sep 13, 2024

Fulcrum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Jul 31, 20242024/Q280.000M / 41.113M--
May 13, 20242024/Q10.000 / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--

Unlock Free Earnings Estimates

Fulcrum Therapeutics Earnings Reports

  • Fulcrum Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 07:21 ET

  • Fulcrum Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 07:19 ET

  • Fulcrum Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 16:10 ET

  • Fulcrum Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 07:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 13, 2024

    Buy

    • Buy

      50.00%

    • Hold

      37.50%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.29%